Oldest pages
Showing below up to 250 results in range #301 to #550.
View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)
- Exponential survival curve (20:01, 12 September 2019)
- Exposure, external or internal (20:01, 12 September 2019)
- Exposure situation (20:02, 12 September 2019)
- Habitual mouth breather (12:42, 13 September 2019)
- Habitual nose breather (12:42, 13 September 2019)
- Half-life, physical (12:43, 13 September 2019)
- Hazard (12:43, 13 September 2019)
- Health Surveillance (12:43, 13 September 2019)
- Heliosphere (12:44, 13 September 2019)
- Hierarchical tissues (12:44, 13 September 2019)
- High level waste (12:45, 13 September 2019)
- Hormones (12:45, 13 September 2019)
- Hyperbaric oxygen (12:46, 13 September 2019)
- Hypertrophic cardiomyopathy (12:48, 13 September 2019)
- Hypoplasia (12:48, 13 September 2019)
- Immune system (12:49, 13 September 2019)
- Incident (12:50, 13 September 2019)
- Inclusiveness (12:50, 13 September 2019)
- Individual decontamination (12:50, 13 September 2019)
- Individual monitoring (12:51, 13 September 2019)
- Individual-related (12:51, 13 September 2019)
- Inhalability (12:53, 13 September 2019)
- Inner bremsstrahlung (12:53, 13 September 2019)
- Institutional control (12:54, 13 September 2019)
- Intermediate level waste (12:54, 13 September 2019)
- Internal conversion electron (12:56, 13 September 2019)
- Interphase death (12:56, 13 September 2019)
- Intervention Level (12:56, 13 September 2019)
- Interventional procedure (12:57, 13 September 2019)
- Iso-effect plots (12:58, 13 September 2019)
- Isomers (12:58, 13 September 2019)
- Isotropic geometry (12:58, 13 September 2019)
- Itinerant (radiation) worker (12:59, 13 September 2019)
- Latent time/period or latency interval (13:01, 13 September 2019)
- Limitation of dose (13:01, 13 September 2019)
- Lineal energy (13:02, 13 September 2019)
- Linear-non-threshold model (13:03, 13 September 2019)
- Low level waste (13:08, 13 September 2019)
- Lymphatic system (13:08, 13 September 2019)
- Macrophage colony stimulating factor (13:08, 13 September 2019)
- Magnetosphere (13:09, 13 September 2019)
- Member of the public (13:10, 13 September 2019)
- Mendelian diseases (13:10, 13 September 2019)
- Mitigation (13:10, 13 September 2019)
- Multistage tumorigenesis (13:11, 13 September 2019)
- Myocardial perfusion (13:12, 13 September 2019)
- Myocardial stress test (13:13, 13 September 2019)
- Naturally occurring radioactive material (13:14, 13 September 2019)
- Necrosis (13:14, 13 September 2019)
- Neurological syndrome (13:14, 13 September 2019)
- Neurovascular syndrome (13:15, 13 September 2019)
- Non-sphericity parameter (13:16, 13 September 2019)
- Nuclear track detectors (13:17, 13 September 2019)
- Particle radiance (13:28, 13 September 2019)
- Peak skin dose (13:28, 13 September 2019)
- Pelagic (13:29, 13 September 2019)
- Percutaneous coronary intervention (13:29, 13 September 2019)
- Pericarditis (13:29, 13 September 2019)
- Pharynx (13:30, 13 September 2019)
- Planned exposure situation (13:30, 13 September 2019)
- Platelet-derived growth factor (13:30, 13 September 2019)
- Practical radiological protection culture (13:32, 13 September 2019)
- Prevailing circumstances (13:32, 13 September 2019)
- Principle of application of dose limits (13:32, 13 September 2019)
- Principle of justification (13:33, 13 September 2019)
- Principle of optimisation (13:33, 13 September 2019)
- Procedural values (13:34, 13 September 2019)
- Progenitor cell (13:35, 13 September 2019)
- Projected dose (13:36, 13 September 2019)
- Protection strategy (13:37, 13 September 2019)
- Protective action (13:37, 13 September 2019)
- Protective action guide (13:38, 13 September 2019)
- Public exposure (13:39, 13 September 2019)
- Radiation modifier (13:41, 13 September 2019)
- Radiation safety officer (13:42, 13 September 2019)
- Radiation worker (13:44, 13 September 2019)
- Radioactive dispersion device (13:44, 13 September 2019)
- Radioactive source (13:45, 13 September 2019)
- Radioactive substance (13:46, 13 September 2019)
- Radioactivity (13:46, 13 September 2019)
- Radiofrequency ablation (13:46, 13 September 2019)
- Radiographer (13:48, 13 September 2019)
- Radiological protection principles (13:49, 13 September 2019)
- Radionuclides of natural origin (13:49, 13 September 2019)
- Radioresponsiveness (13:49, 13 September 2019)
- Radiosensitiser (13:50, 13 September 2019)
- Radiosensitivity, cellular (13:50, 13 September 2019)
- Reasonableness (13:50, 13 September 2019)
- Recovery (13:51, 13 September 2019)
- Recovery responder (13:51, 13 September 2019)
- Reference bioassay function (13:51, 13 September 2019)
- Reference biokinetic model (13:52, 13 September 2019)
- Reference level (13:52, 13 September 2019)
- Rehabilitation of living conditions (13:52, 13 September 2019)
- Relocation (13:53, 13 September 2019)
- Remedial action (13:53, 13 September 2019)
- Remediation (13:53, 13 September 2019)
- Repopulation (13:54, 13 September 2019)
- Representative organism (non-human biota) (13:54, 13 September 2019)
- Representative person (13:54, 13 September 2019)
- Reproductive integrity (13:55, 13 September 2019)
- Residual dose (13:55, 13 September 2019)
- Respiratory protection (13:55, 13 September 2019)
- Retrievability (13:56, 13 September 2019)
- Reversibility (13:56, 13 September 2019)
- Right to know (13:57, 13 September 2019)
- Rigidity (13:58, 13 September 2019)
- Routine monitoring (13:58, 13 September 2019)
- Safety case (13:59, 13 September 2019)
- Safety culture (13:59, 13 September 2019)
- Scintigraphy (13:59, 13 September 2019)
- Self-help protection (14:00, 13 September 2019)
- Slow repair (14:01, 13 September 2019)
- Solar cosmic radiation (14:01, 13 September 2019)
- Solar cycle (14:01, 13 September 2019)
- Solar particle event (14:01, 13 September 2019)
- Source term (14:02, 13 September 2019)
- Source-related (14:02, 13 September 2019)
- South Atlantic anomaly (14:03, 13 September 2019)
- Special (non-routine) monitoring (14:03, 13 September 2019)
- Spontaneous fission (14:03, 13 September 2019)
- Stakeholder (14:04, 13 September 2019)
- Stenosis (14:04, 13 September 2019)
- Storage (14:04, 13 September 2019)
- Subcutaneous tissue (14:05, 13 September 2019)
- Substantial radiation dose level (14:05, 13 September 2019)
- Systemic model (14:06, 13 September 2019)
- Tachycardia (14:10, 13 September 2019)
- Target region (14:10, 13 September 2019)
- Target tissue (14:10, 13 September 2019)
- Telangiectasia (14:11, 13 September 2019)
- Threshold dose for tissue reactions (14:11, 13 September 2019)
- Thyroid blocking (14:11, 13 September 2019)
- Time factor (14:11, 13 September 2019)
- Tissue equivalent material (14:12, 13 September 2019)
- Tolerability (14:12, 13 September 2019)
- Track structure (14:13, 13 September 2019)
- Transfer compartment (14:14, 13 September 2019)
- Transfer rate (14:14, 13 September 2019)
- Transforming growth factor (14:15, 13 September 2019)
- Transparency (14:15, 13 September 2019)
- Trapped particles (14:16, 13 September 2019)
- Types of materials (14:16, 13 September 2019)
- Application of ionising radiation in healthcare (old) (18:00, 9 October 2019)
- Information for patients, family members, carers and the public (old) (18:00, 9 October 2019)
- Information for healthcare providers (old) (18:00, 9 October 2019)
- Application of ionising radiation in healthcare (18:04, 9 October 2019)
- Information for patients, family members, carers and the public (18:11, 9 October 2019)
- Information for healthcare providers (18:21, 9 October 2019)
- ICRPædia Guides (18:33, 9 October 2019)
- List of ICRP Publications on Radiological Protection in Healthcare (13:57, 17 October 2019)
- Guide to Radiological Protection in Healthcare (13:59, 17 October 2019)
- The System of Radiological Protection (15:15, 23 October 2019)
- Quotes from Publications on the System of Radiological Protection (17:58, 23 October 2019)
- Guide to the System of Radiological Protection (15:40, 24 October 2019)
- General Information on Radon (12:41, 30 October 2019)
- System Of Radiation Protection Overview (15:02, 4 November 2019)
- System of radiation protection module 2 (15:11, 4 November 2019)
- Absorbed, Equivalent, and Effective Dose (21:54, 21 November 2019)
- Radon For Governments and Employers (18:19, 3 December 2019)
- Radon For Homeowners and Residents (18:19, 3 December 2019)
- Guide to Radon (07:37, 5 February 2020)
- Main Page (12:31, 18 November 2020)
- Additive risk projection model (20:28, 24 February 2021)
- Attributable risk (20:30, 24 February 2021)
- Dicentric chromosome (20:31, 24 February 2021)
- Effect modifier (20:32, 24 February 2021)
- Hereditary effect (20:33, 24 February 2021)
- Low dose (20:33, 24 February 2021)
- Low dose rate (20:35, 24 February 2021)
- Multiplicative risk projection model (20:36, 24 February 2021)
- Ring chromosome (20:38, 24 February 2021)
- Severe deterministic injury (20:38, 24 February 2021)
- Somatic effect (20:39, 24 February 2021)
- Transgenerational effect (20:40, 24 February 2021)
- Detriment-adjusted risk (20:42, 24 February 2021)
- Elemental dose (20:44, 24 February 2021)
- Multistage carcinogenesis model (20:50, 24 February 2021)
- Mutation component (20:51, 24 February 2021)
- Oncogene (20:52, 24 February 2021)
- Population risk (20:53, 24 February 2021)
- Potentially lethal damage repair (20:54, 24 February 2021)
- Radiation risk (20:55, 24 February 2021)
- Relative life lost (20:56, 24 February 2021)
- Risk model (20:57, 24 February 2021)
- Sublethal damage repair (20:58, 24 February 2021)
- Transfer of risk (20:59, 24 February 2021)
- Tumour suppressor gene (21:00, 24 February 2021)
- Acute radiation syndrome (21:40, 24 February 2021)
- Adaptive response (21:42, 24 February 2021)
- Α/β value (21:46, 24 February 2021)
- ΓH2AX foci (21:46, 24 February 2021)
- Informed consent (21:49, 24 February 2021)
- Supervised area (21:51, 24 February 2021)
- Access control (21:52, 24 February 2021)
- Acute exposure (21:54, 24 February 2021)
- Adventitious source (21:55, 24 February 2021)
- Authorised discharge (21:57, 24 February 2021)
- Backscatter factor (21:59, 24 February 2021)
- Best available techniques (22:00, 24 February 2021)
- Disposal facility (22:02, 24 February 2021)
- Dose modifying factor (22:03, 24 February 2021)
- Exposure pathway (22:05, 24 February 2021)
- Radiological controlled area (22:07, 24 February 2021)
- Life Span Study (22:10, 24 February 2021)
- Detriment (19:17, 25 February 2021)
- Baseline disease rates (19:29, 25 February 2021)
- Biomarker (19:31, 25 February 2021)
- Case–control study (19:33, 25 February 2021)
- Deterministic effect (19:38, 25 February 2021)
- Dose and dose-rate effectiveness factor (15:54, 26 February 2021)
- Dose-threshold hypothesis (15:56, 26 February 2021)
- Tissue reaction (16:00, 26 February 2021)
- Doubling dose (17:10, 26 February 2021)
- Epigenetic effects (17:13, 26 February 2021)
- Excess absolute risk (17:16, 26 February 2021)
- Excess relative risk (17:25, 26 February 2021)
- Homologous recombination (17:26, 26 February 2021)
- Incidence (17:28, 26 February 2021)
- Induced genomic instability (17:30, 26 February 2021)
- Late normal tissue responses (17:31, 26 February 2021)
- LD 50/30 (17:33, 26 February 2021)
- Lifetime risk estimates (17:42, 26 February 2021)
- Linear dose response (17:43, 26 February 2021)
- Linear-quadratic dose response model (17:48, 26 February 2021)
- Stochastic effect (17:58, 26 February 2021)
- Nominal risk coefficient (19:29, 26 February 2021)
- Non-homologous end joining (19:30, 26 February 2021)
- Non-targeted effects (19:31, 26 February 2021)
- Normal tissue complication probability (19:33, 26 February 2021)
- Pooled analysis (19:34, 26 February 2021)
- Quasi-threshold dose (19:35, 26 February 2021)
- Reactive oxygen species (19:36, 26 February 2021)
- Recovery (cellular or tissue) (19:38, 26 February 2021)
- Reference Animal and Plant (19:43, 26 February 2021)
- Relative biological effectiveness (20:22, 26 February 2021)
- Relative risk (20:25, 26 February 2021)
- Risk coefficient (20:30, 26 February 2021)
- Targeted effects (20:32, 26 February 2021)
- Translocation (20:33, 26 February 2021)
- Radiation source (21:04, 26 February 2021)
- Dose-response function (14:57, 28 March 2021)
- Tissue weighting factor (21:32, 28 March 2021)
- Absorption (22:15, 28 March 2021)
- Activation (22:16, 28 March 2021)
- Activity (22:19, 28 March 2021)
- ICRPædia Guide to the System of Radiological Protection (21:44, 3 May 2021)
- Active detection system (19:35, 11 August 2021)
- Additional dose (19:36, 11 August 2021)
- Allometry (19:37, 11 August 2021)